Prestige Consumer Healthcare Inc. logo

Prestige Consumer Healthcare Inc.

PBH | NYSE
Chart Builder DCF Calculator
$46.80
+$1.83 (+4.07%)
At close: Sep 21, 2026, 4:00 PM ET
$46.80
$0 (0.00%)
After-hours: Sep 21, 2026, 4:00 PM ET

Market Data

Market Cap
$2.13B
Enterprise Value
$4.19B
Beta
0.33
Average Volume
644.95K
Shares Outstanding (Diluted)
47.6M
Shares Change YoY
-4.47%
Institutional Ownership
N/A
Exchange
NYSE
ISIN
US74112D1019

Price Performance

Price Change 1M
-9.2%
Price Change 3M
1.6%
Price Change 6M
-23.4%
Price Change YTD
-23.6%
Price Change 1Y
-26.4%
Price Change 3Y
-19.2%
Price Change 5Y
-16.2%
1M CAGR (ann.)
-17.4%
1Y CAGR (ann.)
-29.5%
5Y CAGR (ann.)
-3.4%
All-Time CAGR
7.2%

Valuation

PE Ratio
13.11
Forward PE
9.53
PEG Ratio
-0.76
Forward PEG
1.05
PS Ratio
2.01
Forward PS
1.70
PB Ratio
1.16
P/FCF Ratio
9.12
P/Adj. FCF Ratio
9.45
P/OCF Ratio
8.91
EV/Sales
3.79
EV/EBIT
14.95
EV/EBITDA
13.40
EV/FCF
17.24
Earnings Yield
7.6%
FCF Yield
11.0%
Adj. FCF Yield
10.6%

Financial Health

Net Debt
$1.93B
Total Debt
$2.06B
Cash & Short-Term Investments
$89.13M
Total Assets
$4.57B
Current Ratio
3.23
Quick Ratio
1.99
Debt / Equity Ratio
1.08
Debt / EBITDA
6.60
Debt / FCF
8.49
OCF / Debt
0.12
Interest Coverage
6.30
Altman Z-Score
1.56
Piotroski F-Score
4

Margins & Profitability

Gross Profit Margin
53.3%
Operating Profit Margin
26.3%
EBITDA Margin
28.3%
Net Profit Margin
15.6%
FCF Margin
22.0%
Adj. FCF Margin
21.2%
SBC / Revenue
1.0%
SBC Impact (per share)
-3.5%

Returns

Return on Assets
3.8%
Return on Equity
9.2%
Return on Invested Capital
4.8%
Return on Capital Employed
6.6%
Return on Tangible Assets
25.5%

Historical Growth (CAGR)

Revenue CAGR 3Y
-0.8%
Revenue CAGR 5Y
2.4%
Revenue CAGR 10Y
3.0%
EPS CAGR 3Y
-6.5%
EPS CAGR 5Y
0.2%
EPS CAGR 10Y
10.7%
FCF CAGR 3Y
4.8%
FCF CAGR 5Y
3.1%
FCF CAGR 10Y
3.2%

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
17
EPS Growth Next 3Y
14.2%
Revenue Growth Next 3Y
8.6%
Earnings Date
Nov 4, 2026
EPS Estimate (next Q)
$1.06
EPS Growth Est (next Q)
-0.9%
Revenue Est (next Q)
$329.15M
Revenue Growth Est (next Q)
20.1%

Fair Value Estimates

Graham Number
$56.95
Graham Upside
21.7%
Lynch Fair Value
$17.85
Lynch Upside
-61.9%
Price Target
$81.67
Price Target Upside
74.5%

Cash Flow

Operating Cash Flow
$257.18M
Free Cash Flow
$243.14M
Adj. Free Cash Flow
$234.64M
FCF Per Share
$4.96
OCF Per Share
$5.25
OCF/S Ratio
22.6%

Income Statement

Revenue
$1.1B
Gross Profit
$588.49M
Operating Income
$290.17M
EBITDA
$312.7M
Net Income
$172.01M
EPS (Diluted)
$3.57
Revenue / Employee
$1.24M
Profit / Employee
$193.27K
Employees
890

© 2026 bestshares.com. All rights reserved.